Bronchiolitis News and Research

RSS

Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days

A recent study by French researchers has demonstrated that experimental exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) is capable of inducing mild infection in hamsters and ferrets within 7 – 10 days of exposure. However, the infection completely resolves within 14 days. The study is currently available on the bioRxiv preprint server.

28 Sep 2020

Study presents early data on SARS‐CoV ‐2 testing, outcomes at Australian children’s hospital

In the first 30 days since seeing their first patient, the number of children testing positive to COVID-19 at an Australian tertiary pediatric hospital has been low and none who contracted the virus required in-hospital treatment, according to a new study.

21 May 2020

Spanish study shows infections in children occur early in COVID-19 epidemics

With the spread of COVID-19, scientists are finding out more about the disease. One major aspect that is being studied is how the virus affects children. A new report from Spain, published in the journal JAMA Pediatrics in April 2020, shows that pediatric populations are infected early in the epidemic and that about 10% of those with symptoms suggestive of infection test positive. Severe infection can also occur among children, requiring hospitalization and intensive care.

8 Apr 2020

Reducing albuterol use in children with bronchiolitis without compromising care

Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients.

14 Jan 2020

NTU scientists find potential route to disabling viruses causing severe respiratory diseases

A team of molecular and structural biologists from Nanyang Technological University, Singapore have found a potential new route to disabling respiratory syncytial virus and human metapneumovirus after elucidating the structure of one of its key components.

9 Dec 2019

New technology developed for treatment of children suffering from respiratory diseases

A new technology to unblock and remove secretions from the respiratory tract of children has been developed as part of a collaboration between researchers at Ben-Gurion University of the Negev and its affiliated Soroka University Medical Center, Cincinnati Children's Hospital Medical Center, and the University of Cincinnati.

4 Dec 2019

New research case report describes lung injury related to e-cigarette use

A research case report describing lung injury related to e-cigarette use in a 17-year-old Canadian may be the first documented case of a new form of damage from vaping products.

21 Nov 2019

Inhaled immunosuppressant could improve prognosis of lung transplant patients

University of Maryland School of Medicine researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by using an inhaled form of the immunosuppression drug cyclosporine.

13 Nov 2019

Penn researcher-led study aims to improve long-term outcomes of lung transplants

Lung transplantation can be a life-extending option, but severe postoperative complications-including reduced lung function caused by organ rejection-often affect a recipients' quality of life and limit long-term survival.

17 Oct 2019

AACN grants support nurse-driven research designed to improve critical care nursing practice

The American Association of Critical-Care Nurses announces the recipients of its annual research grants. Clinicians and researchers are invited to submit projects by Nov. 1, 2019, for the next application cycle, with total available funding of $160,000.

16 Oct 2019

Avoiding overtesting in the emergency department could create significant health care savings

An emergency department is sometimes the first place a person thinks to go for health care.

27 Jun 2019

Nicotine concentration in JUUL e-cigarette products is dangerously high, finds study

Little is known about the potential health effects of JUUL e-cigarette products that have recently risen in popularity, especially among adolescents.

9 Apr 2019

Study offers new insights for vaccine development to prevent RSV disease

In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough.

27 Mar 2019

Infants with bronchiolitis are at increased risk of hospitalization for asthma in preschool years

Infants who are admitted to hospital with the common infection bronchiolitis are at increased risk of further emergency hospital admissions for asthma, wheezing and respiratory illness in the first five years of their life.

6 Mar 2019

E-cigarette flavorings shown to be harmful to the human lungs

Scientists have discovered that two chemicals that are commonly used to flavor e-cigarettes can cause harm to the human lungs.

1 Feb 2019

Chemicals used to flavor e-cigs may impair lung function

Two chemicals widely used to flavor electronic cigarettes may be impairing the function of cilia in the human airway, according to a new study led by Harvard T.H. Chan School of Public Health.

1 Feb 2019

A promising, effective vaccine for common respiratory disease

Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance protection against this serious disease and reduce inflammation in the body after exposure to the virus, according to a study led by Georgia State University.

18 Dec 2018

NIAID launches clinical trial of investigational RSV vaccine

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus.

14 Jun 2018

Brief elevation of airborne particulate matter linked to respiratory infection in children

Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.

16 Apr 2018

Brief exposure to pollution-causing particles triggers lung infections in children

Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3% of the diameter of human hair, is associated with the development of acute lower respiratory infection in young children, according to newly published research.

13 Apr 2018